.png)
Osteoarthritis Drugs Market By Drug Class, Route Of Administration and Distribution Channel - Global Industry Analysis And Forecast To 2027
Published On : January 2019 Pages : 165 Category: Pharma & Healthcare Report Code : HC012426
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Osteoarthritis Drugs Market By Drug Class (Viscosupplementation Agents, NSAIDs and Corticosteroids), Route Of Administration (Topical, Parenteral and Oral) and Distribution Channel (Online Pharmacies, Retail Pharmacies and Hospital Pharmacies) - Global Industry Analysis And Forecast To 2027
Industry Outlook
Therefore, the Osteoarthritis Drugs Market is anticipated to expand and has tremendous scope during the forecast period. The global Osteoarthritis Drugs Market anticipated to flourish in the future by growing at a significantly higher CAGR. Osteoarthritis otherwise called degenerative arthritis is the most ordinarily occurring ceaseless condition that influences joints, particularly those in the neck, knees, and lower back. Osteoarthritis prompts serious joint pain and firmness of the body part that has been affected. These signs may happen in the underlying stages following some physical exercise, nonetheless, holds on long after the movement. Other side effects of osteoarthritis incorporate inhibited movement, joint swelling and deadness of the legs and arms.
Drivers and Restraints
Increasing expenditure on R&D, expanded predominance of osteoarthritis over the globe, expanded aged populace, ascend in awareness with respect to degenerative bone infections in creating nations, and rich pipeline of inventive treatment choices are a few factors that are anticipated to help the worldwide osteoarthritis market amid the figure time frame. In addition, expanding research and development exercises in ailment adjusting medications and flood in speculation by key players in the clinical investigations of advanced treatment alternatives are anticipated to push the worldwide osteoarthritis drugs market amid the figure time frame.
Regional Insights
On a global front, the Osteoarthritis Drugs Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North America holds the biggest share of the worldwide osteoarthritis treatment market, attributable to the high commonness rate of arthritis in the area.
Osteoarthritis Drugs Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Zimmer Biomet Holdings Inc.
- Horizon Pharma plc
- Flexion Therapeutics Inc.
- Pfizer Inc.
- Alkem Laboratories
- Sanofi
- Chugai Pharmaceutical Co. Limited
- Anika Therapeutics Inc.
- Bioventus Inc.
- Ferring B.V.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Osteoarthritis Drugs Market, By Drug Class, Estimates and Forecast, 2017-2027 ($Million)
o Viscosupplementation Agents
o NSAIDs
o Corticosteroids
o Osteoarthritis Drugs Market, By Route Of Administration, Estimates and Forecast, 2017-2027 ($Million)
o Topical
o Parenteral
o Oral
o Osteoarthritis Drugs Market, By Distribution Channel, Estimates and Forecast, 2017-2027 ($Million)
o Online Pharmacies
o Retail Pharmacies
o Hospital Pharmacies
o Osteoarthritis Drugs Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Osteoarthritis Drugs Market, By Country
o U.S. Osteoarthritis Drugs Market
o Canada Osteoarthritis Drugs Market
o Mexico Osteoarthritis Drugs Market
o Europe
§ Europe Osteoarthritis Drugs Market, By Country
o Germany Osteoarthritis Drugs Market
o UK Osteoarthritis Drugs Market
o France Osteoarthritis Drugs Market
o Russia Osteoarthritis Drugs Market
o Italy Osteoarthritis Drugs Market
o Rest of Europe Osteoarthritis Drugs Market
o Asia-Pacific
§ Asia-Pacific Osteoarthritis Drugs Market, By Country
o China Osteoarthritis Drugs Market
o Japan Osteoarthritis Drugs Market
o South Korea Osteoarthritis Drugs Market
o India Osteoarthritis Drugs Market
o Southeast Asia Osteoarthritis Drugs Market
o Rest of Asia-Pacific Osteoarthritis Drugs Market
o South America
§ South America Osteoarthritis Drugs Market, By Country
o Brazil Osteoarthritis Drugs Market
o Argentina Osteoarthritis Drugs Market
o Columbia Osteoarthritis Drugs Market
o Rest of South America Osteoarthritis Drugs Market
o Middle East and Africa
§ Middle East and Africa Osteoarthritis Drugs Market, By Country
o Saudi Arabia Osteoarthritis Drugs Market
o UAE Osteoarthritis Drugs Market
o Egypt Osteoarthritis Drugs Market
o Nigeria Osteoarthritis Drugs Market
o South Africa Osteoarthritis Drugs Market
o Rest of MEA Osteoarthritis Drugs Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Osteoarthritis Drugs Market, By Drug Class
5.1. Introduction
5.2. Global Osteoarthritis Drugs Revenue and Market Share by Drug Class (2017-2027)
5.2.1. Global Osteoarthritis Drugs Revenue and Revenue Share by Drug Class (2017-2027)
5.3. Viscosupplementation Agents
5.3.1. Global Viscosupplementation Agents Revenue and Growth Rate (2017-2027)
5.4. NSAIDs
5.4.1. Global NSAIDs Revenue and Growth Rate (2017-2027)
5.5. Corticosteroids
5.5.1. Global Corticosteroids Revenue and Growth Rate (2017-2027)
6. Osteoarthritis Drugs Market, By Route Of Administration
6.1. Introduction
6.2. Global Osteoarthritis Drugs Revenue and Market Share by Route Of Administration (2017-2027)
6.2.1. Global Osteoarthritis Drugs Revenue and Revenue Share by Route Of Administration (2017-2027)
6.3. Topical
6.3.1. Global Topical Revenue and Growth Rate (2017-2027)
6.4. Parenteral
6.4.1. Global Parenteral Revenue and Growth Rate (2017-2027)
6.5. Oral
6.5.1. Global Oral Revenue and Growth Rate (2017-2027)
7. Osteoarthritis Drugs Market, By Distribution Channel
7.1. Introduction
7.2. Global Osteoarthritis Drugs Revenue and Market Share by Distribution Channel (2017-2027)
7.2.1. Global Osteoarthritis Drugs Revenue and Revenue Share by Distribution Channel (2017-2027)
7.3. Online Pharmacies
7.3.1. Global Online Pharmacies Revenue and Growth Rate (2017-2027)
7.4. Retail Pharmacies
7.4.1. Global Retail Pharmacies Revenue and Growth Rate (2017-2027)
7.5. Hospital Pharmacies
7.5.1. Global Hospital Pharmacies Revenue and Growth Rate (2017-2027)
8. Osteoarthritis Drugs Market, By Region
8.1. Introduction
8.2. Global Osteoarthritis Drugs Revenue and Market Share by Regions
8.2.1. Global Osteoarthritis Drugs Revenue by Regions (2017-2027)
8.3. North America Osteoarthritis Drugs by Countries
8.3.1. North America Osteoarthritis Drugs Revenue and Growth Rate (2017-2027)
8.3.2. North America Osteoarthritis Drugs Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Osteoarthritis Drugs by Countries
8.4.1. Europe Osteoarthritis Drugs Revenue and Growth Rate (2017-2027)
8.4.2. Europe Osteoarthritis Drugs Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Osteoarthritis Drugs by Countries
8.5.1. Asia-Pacific Osteoarthritis Drugs Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Osteoarthritis Drugs Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Osteoarthritis Drugs by Countries
8.6.1. South America Osteoarthritis Drugs Revenue and Growth Rate (2017-2027)
8.6.2. South America Osteoarthritis Drugs Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Osteoarthritis Drugs by Countries
8.7.1. Middle East and Africa Osteoarthritis Drugs Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Osteoarthritis Drugs Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Zimmer Biomet Holdings Inc.
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Revenue and Market Share
9.2. Horizon Pharma plc
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Revenue and Market Share
9.3. Flexion Therapeutics Inc.
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Revenue and Market Share
9.4. Pfizer Inc.
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Revenue and Market Share
9.5. Alkem Laboratories
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Revenue and Market Share
9.6. Sanofi
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Revenue and Market Share
9.7. Chugai Pharmaceutical Co. Limited
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Revenue and Market Share
9.8. Anika Therapeutics Inc.
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Revenue and Market Share
9.9. Bioventus Inc.
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Revenue and Market Share
9.10. Ferring B.V.
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Revenue and Market Share
10. Global Osteoarthritis Drugs Market Competition, by Manufacturer
10.1. Global Osteoarthritis Drugs Revenue and Market Share by Manufacturer (2017-2017)
10.2. Global Osteoarthritis Drugs Price By Region (2017-2017)
10.3. Top 5 Osteoarthritis Drugs Manufacturer Market Share
10.4. Market Competition Trend
11. Osteoarthritis Drugs Market Forecast (2017-2027)
11.1. Global Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Osteoarthritis Drugs Market Forecast by Regions (2017-2027)
11.2.1. North America Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.1.1. United States Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.1.2. Canada Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.1.3. Mexico Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.2. Europe Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.2.1. Germany Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.2.2. France Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.2.3. UK Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.2.4. Russia Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.2.5. Italy Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.3. Asia-Pacific Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.3.1. China Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.3.2. Japan Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.3.3. Korea Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.3.4. India Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.4. South America Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.4.1. Brazil Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.4.2. Argentina Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.4.3. Columbia Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.4.4. Rest of South America Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.5. Middle East and Africa Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.5.3. Egypt Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.5.4. Nigeria Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.5.5. South Africa Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.5.6. Turkey Osteoarthritis Drugs Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Osteoarthritis Drugs Market Forecast (2017-2027)
11.3. Osteoarthritis Drugs Market Forecast by Drug Class (2017-2027)
11.3.1. Osteoarthritis Drugs Forecast by Drug Class (2017-2027)
11.3.2. Osteoarthritis Drugs Market Share Forecast by Drug Class (2017-2027)
11.4. Osteoarthritis Drugs Market Forecast by Route Of Administration (2017-2027)
11.4.1. Osteoarthritis Drugs Forecast by Route Of Administration (2017-2027)
11.4.2. Osteoarthritis Drugs Market Share Forecast by Route Of Administration (2017-2027)
11.5. Osteoarthritis Drugs Market Forecast by Distribution Channel (2017-2027)
11.5.1. Osteoarthritis Drugs Forecast by Distribution Channel (2017-2027)
11.5.2. Osteoarthritis Drugs Market Share Forecast by Distribution Channel (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Osteoarthritis Drugs Revenue and Revenue Share by Drug Class (2017-2018)
Figure Global Viscosupplementation Agents Revenue and Growth Rate (2017-2018)
Figure Global NSAIDs Revenue and Growth Rate (2017-2018)
Figure Global Corticosteroids Revenue and Growth Rate (2017-2018)
Table Global Osteoarthritis Drugs Revenue and Revenue Share by Route Of Administration (2017-2018)
Figure Global Topical Revenue and Growth Rate (2017-2018)
Figure Global Parenteral Revenue and Growth Rate (2017-2018)
Figure Global Oral Revenue and Growth Rate (2017-2018)
Table Global Osteoarthritis Drugs Revenue and Revenue Share by Distribution Channel (2017-2018)
Figure Global Online Pharmacies Revenue and Growth Rate (2017-2018)
Figure Global Retail Pharmacies Revenue and Growth Rate (2017-2018)
Figure Global Hospital Pharmacies Revenue and Growth Rate (2017-2018)
Table Global Osteoarthritis Drugs Revenue by Regions (2017-2018)
Figure North America Osteoarthritis Drugs Growth Rate (2017-2018)
Figure North America Osteoarthritis Drugs Revenue and Growth Rate (2017-2018)
Figure North America Osteoarthritis Drugs by Countries (2017-2018)
Figure North America Osteoarthritis Drugs Revenue (Million USD) by Countries (2017-2018)
Figure United States Osteoarthritis Drugs Growth Rate (2017-2018)
Figure United States Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Osteoarthritis Drugs Growth Rate (2017-2018)
Figure Canada Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Osteoarthritis Drugs Growth Rate (2017-2018)
Figure Mexico Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Osteoarthritis Drugs Growth Rate (2017-2018)
Figure Europe Osteoarthritis Drugs Revenue and Growth Rate (2017-2018)
Figure Europe Osteoarthritis Drugs by Countries (2017-2018)
Figure Europe Osteoarthritis Drugs Revenue (Million USD) by Countries (2017-2018)
Figure Germany Osteoarthritis Drugs Growth Rate (2017-2018)
Figure Germany Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Osteoarthritis Drugs Growth Rate (2017-2018)
Figure France Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Osteoarthritis Drugs Growth Rate (2017-2018)
Figure UK Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Osteoarthritis Drugs Growth Rate (2017-2018)
Figure Russia Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Osteoarthritis Drugs Growth Rate (2017-2018)
Figure Italy Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Osteoarthritis Drugs Growth Rate (2017-2018)
Figure Rest of Europe Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Osteoarthritis Drugs Growth Rate (2017-2018)
Figure Asia-Pacific Osteoarthritis Drugs Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Osteoarthritis Drugs by Countries (2017-2018)
Figure Asia-Pacific Osteoarthritis Drugs Revenue (Million USD) by Countries (2017-2018)
Figure China Osteoarthritis Drugs Growth Rate (2017-2018)
Figure China Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Osteoarthritis Drugs Growth Rate (2017-2018)
Figure Japan Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Osteoarthritis Drugs Growth Rate (2017-2018)
Figure Korea Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Osteoarthritis Drugs Growth Rate (2017-2018)
Figure India Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Osteoarthritis Drugs Growth Rate (2017-2018)
Figure Southeast Asia Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Osteoarthritis Drugs Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Osteoarthritis Drugs Growth Rate (2017-2018)
Figure South America Osteoarthritis Drugs Revenue and Growth Rate (2017-2018)
Figure South America Osteoarthritis Drugs by Countries (2017-2018)
Figure South America Osteoarthritis Drugs Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Osteoarthritis Drugs Growth Rate (2017-2018)
Figure Brazil Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Osteoarthritis Drugs Growth Rate (2017-2018)
Figure Argentina Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Osteoarthritis Drugs Growth Rate (2017-2018)
Figure Columbia Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Osteoarthritis Drugs Growth Rate (2017-2018)
Figure Rest of South America Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Osteoarthritis Drugs Growth Rate (2017-2018)
Figure Middle East and Africa Osteoarthritis Drugs Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Osteoarthritis Drugs by Countries (2017-2018)
Figure Middle East and Africa Osteoarthritis Drugs Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Osteoarthritis Drugs Growth Rate (2017-2018)
Figure Saudi Arabia Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Osteoarthritis Drugs Growth Rate (2017-2018)
Figure United Arab Emirates Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Osteoarthritis Drugs Growth Rate (2017-2018)
Figure Egypt Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Osteoarthritis Drugs Growth Rate (2017-2018)
Figure Nigeria Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Osteoarthritis Drugs Growth Rate (2017-2018)
Figure South Africa Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Osteoarthritis Drugs Growth Rate (2017-2018)
Figure Turkey Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Osteoarthritis Drugs Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Table Zimmer Biomet Holdings Inc. Osteoarthritis Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Horizon Pharma plc Osteoarthritis Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Flexion Therapeutics Inc. Osteoarthritis Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer Inc. Osteoarthritis Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Alkem Laboratories Osteoarthritis Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sanofi Osteoarthritis Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Chugai Pharmaceutical Co. Limited Osteoarthritis Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Anika Therapeutics Inc. Osteoarthritis Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bioventus Inc. Osteoarthritis Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Ferring B.V. Osteoarthritis Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Osteoarthritis Drugs Market Share by Manufacturer
Figure Global Osteoarthritis Drugs Revenue and Market Share by Manufacturer
Table Global Osteoarthritis Drugs Price by Region (2017-2017)
Figure Top 5 Osteoarthritis Drugs Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Osteoarthritis Drugs Revenue (Millions USD) and Growth Rate (2018-2025)
Table Osteoarthritis Drugs Market Forecast by Regions (2018-2025)
Figure North America Osteoarthritis Drugs Market Forecast (2018-2025)
Figure United States Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Canada Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Mexico Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Europe Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Germany Osteoarthritis Drugs Market Forecast (2018-2025)
Figure France Osteoarthritis Drugs Market Forecast (2018-2025)
Figure UK Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Russia Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Italy Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Rest of Europe Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Asia-Pacific Osteoarthritis Drugs Market Forecast (2018-2025)
Figure China Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Japan Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Korea Osteoarthritis Drugs Market Forecast (2018-2025)
Figure India Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Southeast Asia Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Osteoarthritis Drugs Market Forecast (2018-2025)
Figure South America Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Brazil Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Argentina Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Columbia Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Rest of South America Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Middle East and Africa Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Saudi Arabia Osteoarthritis Drugs Market Forecast (2018-2025)
Figure United Arab Emirates Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Egypt Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Nigeria Osteoarthritis Drugs Market Forecast (2018-2025)
Figure South Africa Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Turkey Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Osteoarthritis Drugs Market Forecast (2018-2025)
Figure Global Osteoarthritis Drugs Forecast by Drug Class (2018-2025)
Figure Global Osteoarthritis Drugs Market Share Forecast by Drug Class (2018-2025)
Figure Global Osteoarthritis Drugs Forecast by Drug Class (2018-2025)
Figure Global Osteoarthritis Drugs Forecast by Route Of Administration (2018-2025)
Figure Global Osteoarthritis Drugs Market Share Forecast by Route Of Administration (2018-2025)
Figure Global Osteoarthritis Drugs Forecast by Route Of Administration (2018-2025)
Figure Global Osteoarthritis Drugs Forecast by Distribution Channel (2018-2025)
Figure Global Osteoarthritis Drugs Market Share Forecast by Distribution Channel (2018-2025)
Figure Global Osteoarthritis Drugs Forecast by Distribution Channel (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|